C07D 317/30
Radicals substituted by carbon atoms having three bonds to hetero atoms with
Official title: Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
C07D317/30 (Radicals substituted by carbon atoms having three bonds to hetero atoms with) appears on 354 US grants and 198 published applications in this corpus.
Search patents in C07D- Granted patents
- 354
- Published applications
- 198
- Assignees
- 169
- Inventors
- 823
- Latest grant
- 7 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 19 | 0 |
| 1977 | 11 | 0 |
| 1978 | 14 | 0 |
| 1979 | 11 | 0 |
| 1980 | 21 | 0 |
| 1981 | 11 | 0 |
| 1982 | 10 | 0 |
| 1983 | 10 | 0 |
| 1984 | 7 | 0 |
| 1985 | 13 | 0 |
| 1986 | 4 | 0 |
| 1987 | 3 | 0 |
| 1988 | 4 | 0 |
| 1989 | 9 | 0 |
| 1990 | 9 | 0 |
| 1991 | 7 | 0 |
| 1992 | 3 | 0 |
| 1993 | 4 | 0 |
| 1994 | 4 | 0 |
| 1995 | 3 | 0 |
| 1996 | 3 | 0 |
| 1997 | 4 | 0 |
| 1998 | 12 | 0 |
| 1999 | 15 | 0 |
| 2000 | 7 | 0 |
| 2001 | 14 | 0 |
| 2002 | 3 | 8 |
| 2003 | 5 | 3 |
| 2004 | 4 | 6 |
| 2005 | 0 | 3 |
| 2006 | 3 | 9 |
| 2007 | 5 | 9 |
| 2008 | 3 | 14 |
| 2009 | 4 | 9 |
| 2010 | 2 | 5 |
| 2011 | 5 | 15 |
| 2012 | 5 | 8 |
| 2013 | 12 | 14 |
| 2014 | 11 | 10 |
| 2015 | 11 | 11 |
| 2016 | 4 | 15 |
| 2017 | 6 | 3 |
| 2018 | 7 | 9 |
| 2019 | 4 | 2 |
| 2020 | 3 | 1 |
| 2021 | 2 | 3 |
| 2022 | 4 | 9 |
| 2023 | 8 | 9 |
| 2024 | 2 | 8 |
| 2025 | 6 | 6 |
| 2026 | 3 | 9 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Branched type hetero monodispersed polyethylene glycol, production method thereof, and conjugate thereof7 Jul 2026US 12,674,025 B2Nof Corporation
- Scaleable preparation of polyketides12 May 2026US 12,623,988 B2The Regents of the University of California
- Branched type hetero monodispersed polyethylene glycol, production method thereof, and conjugate thereof24 Mar 2026US 12,583,967 B2Nof Corporation
- Processes and intermediates for preparing MCL1 inhibitors9 Sep 2025US 12,410,146 B2Gilead Sciences, Inc.
- Lipid compounds and lipid nanoparticle compositions19 Aug 2025US 12,391,662 B2Rinuagene Biotechnology Co., Ltd.
- Ionizable lipids and liposomal nanoparticle compositions24 Sep 2026US 2026/0285826 A1Akagera Medicines, Inc.
- Process for preparing solketal acrylate by transesterification17 Sep 2026US 2026/0274813 A1BASF SE
- Scaleable preparation of polyketides20 Aug 2026US 2026/0242319 A1The Regents of the University of California
- Bio-based compounds16 Jul 2026US 2026/0200888 A1Specialty Operations France
- Chemoenzymatic synthesis of polyketides16 Jul 2026US 2026/0201433 A1Aspera Biomedicines, Inc.
Most cited
By later US patents
- Difluoro antivirals and intermediate therefor135US 4,808,614 AEli Lilly and Company · 1989
- Bridged bicyclic aromatic compounds and their use in modulating gene expression of retinoid receptors129US 5,466,861 ALa Jolla Cancer Research Foundation · 1995
- Difluoro antivirals and intermediate therefor120US 4,526,988 AEli Lilly and Company · 1985
- Derivatization of non-natural amino acids and polypeptides61US 7,385,028 B2Ambrx, Inc. · 2008
- Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides60US 7,332,571 B2Ambrx, Inc. · 2008